medwireNews

The long-acting amylin analog cagrilintide promotes notable weight loss during 26 weeks of use, show phase 2 trial findings.

The cardiovascular benefits of the GLP-1 receptor agonist efpeglenatide are unrelated to concurrent SGLT2 inhibitor use, suggests an exploratory analysis of AMPLITUDE-O trial data.

Intra-articular injections of platelet-rich plasma do not reduce knee pain or disease progression for people with symptomatic mild-to-moderate radiographic medial knee osteoarthritis, suggest findings from a randomized controlled trial.

Physicians should be aware of the likelihood of pathologic etiology in advanced breast cancer patients who have sustained fractures of the vertebrae, say US researchers.

A retrospective cohort study shows that patients with systemic lupus erythematosus have similar kidney failure outcomes to non-SLE patients, but a higher risk for death after transplantation.

The bile acid transport inhibitor maralixibat, given at a higher dose than previously tested, may significantly improve cholestasis in children with Alagille syndrome, shows the phase 2 ICONIC trial.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.